ACLS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Damjanov, I
Right arrow Articles by Jewett, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Damjanov, I
Right arrow Articles by Jewett, M.
Annals of Clinical and Laboratory Science, Vol 9, Issue 2, 157-163
Copyright © 1979 by Association of Clinical Scientists


Articles

Leydig cell tumors of the testis

I Damjanov, SM Katz, and MA Jewett

Leydig cell tumors represent approximately one to three percent of all testicular tumors. Whereas in experimental animals predisposing conditions include administration of chemical carcinogens, hormones and heavy metals, environmental or endogenous factors in man are presently unrecognized. Leydig cell tumors do not show preferential lateralization or tendency for bilaterality. The symptoms are related to the local effects or to hormones released into the systemic circulation. Laboratory findings are variable, depending on endocrinological activity. Typical tumors rarely exceed five cm in diameter, are brown on cross section and are composed of polyhedral cells with acidophilic, granular cytoplasm. Ultrastructurally, neoplastic Leydig cells resemble normal Leydig cells. Surgical ablation is curative for benign Leydig cell tumors.





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1979 by the Association of Clinical Scientists.